{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:32:21Z","timestamp":1777984341784,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Amrita Hospital, Faridabad"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15894-7","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T11:39:00Z","timestamp":1776685140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genomic landscape of cholangiocarcinoma in India: ethnic variants and implications for targeted therapy"],"prefix":"10.1186","volume":"26","author":[{"given":"Moushumi","family":"Suryavanshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Ostwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milind","family":"Javle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omshree","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darshana","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivani","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sewanti","family":"Limaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amol","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhawna","family":"Sirohi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankur","family":"Bahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitesh","family":"Rohtagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"issue":"11","key":"15894_CR1","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1002\/cncr.32803","volume":"126","author":"AA Florio","year":"2020","unstructured":"Florio AA, Ferlay J, Znaor A, Ruggieri D, Alvarez CS, Laversanne M, et al. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012. Cancer. 2020;126(11):2666\u201378.","journal-title":"Cancer"},{"issue":"12","key":"15894_CR2","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1001\/jamaoncol.2018.3277","volume":"4","author":"V Sahai","year":"2018","unstructured":"Sahai V, Catalano PJ, Zalupski MM, Lubner SJ, Menge MR, Nimeiri HS, et al. Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma: A Phase 2 Clinical Trial. JAMA Oncol. 2018;4(12):1707.","journal-title":"JAMA Oncol"},{"key":"15894_CR3","doi-asserted-by":"publisher","first-page":"100910","DOI":"10.1016\/j.neo.2023.100910","volume":"42","author":"C Kumar-Sinha","year":"2023","unstructured":"Kumar-Sinha C, Vats P, Tran N, Robinson DR, Gunchick V, Wu YM, et al. Genomics driven precision oncology in advanced biliary tract cancer improves survival. Neoplasia. 2023;42:100910.","journal-title":"Neoplasia"},{"key":"15894_CR4","doi-asserted-by":"publisher","unstructured":"Qurashi M, Vithayathil M, Khan SA. Epidemiology of cholangiocarcinoma. Eur J Surg Oncol. 2025;51(2):107064. https:\/\/doi.org\/10.1016\/j.ejso.2023.107064","DOI":"10.1016\/j.ejso.2023.107064"},{"key":"15894_CR5","doi-asserted-by":"publisher","first-page":"768009","DOI":"10.3389\/fonc.2021.768009","volume":"11","author":"A Manne","year":"2021","unstructured":"Manne A, Woods E, Tsung A, Mittra A. Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology. Front Oncol. 2021;11:768009.","journal-title":"Front Oncol"},{"issue":"17","key":"15894_CR6","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-18-0078","volume":"24","author":"MA Lowery","year":"2018","unstructured":"Lowery MA, Ptashkin R, Jordan E, Berger MF, Zehir A, Capanu M, et al. Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention. Clin Cancer Res. 2018;24(17):4154\u201361.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"15894_CR7","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/ng.2806","volume":"45","author":"W Chan-on","year":"2013","unstructured":"Chan-on W, Nairism\u00e4gi ML, Ong CK, Lim WK, Dima S, Pairojkul C, et al. Exome sequencing identifies distinct mutational patterns in liver fluke\u2013related and non-infection-related bile duct cancers. Nat Genet. 2013;45(12):1474\u20138.","journal-title":"Nat Genet"},{"issue":"12","key":"15894_CR8","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/ng.2813","volume":"45","author":"Y Jiao","year":"2013","unstructured":"Jiao Y, Pawlik TM, Anders RA, Selaru FM, Streppel MM, Lucas DJ, et al. Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas. Nat Genet. 2013;45(12):1470\u20133.","journal-title":"Nat Genet"},{"issue":"6","key":"15894_CR9","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/ng.2273","volume":"44","author":"CK Ong","year":"2012","unstructured":"Ong CK, Subimerb C, Pairojkul C, Wongkham S, Cutcutache I, Yu W, et al. Exome sequencing of liver fluke-associated cholangiocarcinoma. Nat Genet. 2012;44(6):690\u20133.","journal-title":"Nat Genet"},{"issue":"3","key":"15894_CR10","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/hep.31829","volume":"74","author":"T Boerner","year":"2021","unstructured":"Boerner T, Drill E, Pak LM, Nguyen B, Sigel CS, Doussot A, et al. Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma. Hepatology. 2021;74(3):1429\u201344.","journal-title":"Hepatology"},{"issue":"6","key":"15894_CR11","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.ccell.2019.04.007","volume":"35","author":"R Xue","year":"2019","unstructured":"Xue R, Chen L, Zhang C, Fujita M, Li R, Yan SM, et al. Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes. Cancer Cell. 2019;35(6):932\u2013e9478.","journal-title":"Cancer Cell"},{"issue":"14","key":"15894_CR12","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1158\/1078-0432.CCR-21-0412","volume":"27","author":"JS Jolissaint","year":"2021","unstructured":"Jolissaint JS, Soares KC, Seier KP, Kundra R, G\u00f6nen M, Shin PJ, et al. Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumour Genomics in Patient Selection. Clin Cancer Res. 2021;27(14):4101\u20138.","journal-title":"Clin Cancer Res"},{"key":"15894_CR13","doi-asserted-by":"publisher","first-page":"6087","DOI":"10.1038\/ncomms7087","volume":"6","author":"D Sia","year":"2015","unstructured":"Sia D, Losic B, Moeini A, Cabellos L, Hao K, Revill K, et al. Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma. Nat Commun. 2015;6:6087.","journal-title":"Nat Commun"},{"issue":"1","key":"15894_CR14","doi-asserted-by":"publisher","first-page":"5696","DOI":"10.1038\/ncomms6696","volume":"5","author":"S Zou","year":"2014","unstructured":"Zou S, Li J, Zhou H, Frech C, Jiang X, Chu JSC, et al. Mutational landscape of intrahepatic cholangiocarcinoma. Nat Commun. 2014;5(1):5696.","journal-title":"Nat Commun"},{"issue":"10","key":"15894_CR15","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1158\/2159-8290.CD-17-0368","volume":"7","author":"A Jusakul","year":"2017","unstructured":"Jusakul A, Cutcutache I, Yong CH, Lim JQ, Huang MN, Padmanabhan N, et al. Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma. Cancer Discov. 2017;7(10):1116\u201335.","journal-title":"Cancer Discov"},{"issue":"3","key":"15894_CR16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cld.2020.04.005","volume":"24","author":"AP Buckholz","year":"2020","unstructured":"Buckholz AP, Brown RS. Cholangiocarcinoma: Diagnosis and Management. Clin Liver Dis. 2020;24(3):421\u201336.","journal-title":"Clin Liver Dis"},{"key":"15894_CR17","doi-asserted-by":"publisher","first-page":"963753","DOI":"10.3389\/fonc.2022.963753","volume":"12","author":"M Ledenko","year":"2022","unstructured":"Ledenko M, Antwi SO, Arima S, Driscoll J, Furuse J, Kl\u00fcmpen HJ, et al. Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials. Front Oncol. 2022;12:963753.","journal-title":"Front Oncol"},{"issue":"3","key":"15894_CR18","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"15894_CR19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/PO.18.00414","volume":"4","author":"J Cao","year":"2020","unstructured":"Cao J, Hu J, Liu S, Meric-Bernstam F, Abdel-Wahab R, Xu J, et al. Intrahepatic Cholangiocarcinoma: Genomic Heterogeneity Between Eastern and Western Patients. JCO Precis Oncol. 2020;4:557\u201369.","journal-title":"JCO Precis Oncol"},{"key":"15894_CR20","doi-asserted-by":"publisher","first-page":"276","DOI":"10.18632\/oncotarget.28380","volume":"14","author":"M Nagao","year":"2023","unstructured":"Nagao M, Mizukoshi K, Nakayama S, Namikawa M, Hiramatsu Y, Maruno T, et al. p53 protects against formation of extrahepatic biliary precancerous lesions in the context of oncogenic KRAS. Oncotarget. 2023;14:276\u20139.","journal-title":"Oncotarget"},{"issue":"4","key":"15894_CR21","doi-asserted-by":"publisher","first-page":"751","DOI":"10.21037\/jgo.2019.03.10","volume":"10","author":"AN Boscoe","year":"2019","unstructured":"Boscoe AN, Rolland C, Kelley RK. Frequency and prognostic significance of isocitrate dehydrogenase 1 mutations in cholangiocarcinoma: a systematic literature review. J Gastrointest Oncol. 2019;10(4):751\u201365.","journal-title":"J Gastrointest Oncol"},{"key":"15894_CR22","unstructured":"Humans IWG on the E of CR to. OPISTHORCHIS VIVERRINI AND CLONORCHIS SINENSIS. In: Biological Agents. International Agency for Research on Cancer. 2012 Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK304354\/. [cited 2024 Dec 8]."},{"issue":"3","key":"15894_CR23","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/MOG.0000000000000162","volume":"31","author":"A Jusakul","year":"2015","unstructured":"Jusakul A, Kongpetch S, Teh BT. Genetics of Opisthorchis viverrini-related cholangiocarcinoma. Curr Opin Gastroenterol. 2015;31(3):258\u201363.","journal-title":"Curr Opin Gastroenterol"},{"key":"15894_CR24","doi-asserted-by":"publisher","first-page":"S226","DOI":"10.1016\/j.annonc.2023.09.1410","volume":"34","author":"N Rohatgi","year":"2023","unstructured":"Rohatgi N, Agarwal A, Maniar V, Patil S, Bahl A, Advani S, et al. 117P Genomic landscape of biliary tract cancers from India show distinct geographic variation. Ann Oncol. 2023;34:S226.","journal-title":"Ann Oncol"},{"issue":"10","key":"15894_CR25","doi-asserted-by":"publisher","first-page":"7413","DOI":"10.1007\/s00432-023-04693-3","volume":"149","author":"M Gurav","year":"2023","unstructured":"Gurav M, Epari S, Gogte P, Pai T, Deshpande G, Karnik N, et al. Targeted molecular profiling of solid tumours-Indian tertiary cancer centre experience. J Cancer Res Clin Oncol. 2023;149(10):7413\u201325.","journal-title":"J Cancer Res Clin Oncol"},{"key":"15894_CR26","doi-asserted-by":"crossref","unstructured":"Limaye S, Shreenivas A, Patil D, Vyas S, George IA, Sambath J et al. Actionable genomic landscape of biliary tract cancer in the Indian population. Oncologist. 2026;31(3):oyaf430.","DOI":"10.1093\/oncolo\/oyaf430"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15894-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15894-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15894-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T09:43:06Z","timestamp":1776937386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15894-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15894"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15894-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8171284\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Amrita Hospital, Faridabad provided ethics approval for this study under approval number AIMS-IEC-BAS-05-24-001. As this is a retrospective study, a formal informed consent waiver was granted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. The manuscript contains original data, and no individual-identifying information is included; therefore, consent for publication is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"518"}}